Why Better Communication — Not Just Better Design — Will Define The Next Era Of Vaccine Research

Panelists: Chijioke Bennett, Executive Director of Clinical Development, Novavax, Jeff Huntsman, Chief Commercial Officer at EmVenio Clinical Research, Roshan Ramanathan, Executive Director at Bridges Initiative for Vaccine Regulatory Science and Practice, and former Vice President, Vaccine Development Lead, GSK, Harpreet Singh, Chief Medical Officer, Precision for Medicine, and Missy Taylor, Vice President of Global Clinical Operations, Veristat

As vaccine research evolves, improving trial access and representation requires more than operational innovation. Industry leaders from sponsor organizations, regulatory, and clinical operations backgrounds argue that communication, trust, and community engagement have become critical drivers of research participation and trial success.

Trust is often built through local relationships and shared experiences rather than institutional messaging alone, making community-centered engagement an essential component of modern clinical research. Panelists also explore how patient-centric study design, clearer communication between sponsors and regulators, and a deeper understanding of real-world participant needs can help overcome persistent barriers to enrollment and retention.

Discover why communication can no longer be treated as a supporting function and how embedding it into trial strategy may be key to building confidence, improving inclusivity, and generating evidence that better reflects the populations researchers aim to serve.